AbbVie

Latest news

• 
  Prediction: Eli Lilly Could Be the Next $2 Trillion Drugmaker (opens in a new tab)

  Oct 2, 2026

• 
  Can ABBV's New Parkinson's Pill Strengthen Its Neuroscience Franchise? (opens in a new tab)

  Oct 2, 2026

• 
  J&J's Innovative Medicine Segment in Q3: Key Growth Drivers to Watch (opens in a new tab)

  Oct 2, 2026

• 
  How Has Pfizer's Story Changed? (opens in a new tab)

  Oct 2, 2026

• AbbVie vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026? (opens in a new tab)

  The Motley Fool · Oct 1, 2026

• Johnson & Johnson vs. Eli Lilly: Which Pharma Stock Can Make Your Portfolio Healthier in 2026? (opens in a new tab)

  Oct 1, 2026

• AbbVie (ABBV) Stock May Be 41% Undervalued Following JUVMO Approval (opens in a new tab)

  Yahoo Finance · Oct 1, 2026

• 3 takeaways from a European obesity scientific meeting (opens in a new tab)

  Oct 1, 2026

• What Is The Options Market Telling Us About Eli Lilly Stock? (opens in a new tab)

  Oct 1, 2026

• AbbVie Presents Long-Term RINVOQ® (upadacitinib) Data Showing Continued Repigmentation in Non-Segmental Vitiligo (opens in a new tab)

  Oct 1, 2026

• AbbVie to Host Third-Quarter 2026 Earnings Conference Call (opens in a new tab)

  Investing News Network · Oct 1, 2026

• 
  5 Solid Dividend Stocks to Buy Now (opens in a new tab)

  Oct 1, 2026

• AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It (opens in a new tab)

  Oct 1, 2026

• 5 High-Yield Dividend Stocks That Pass the Coverage Test (Not Just the Yield Test) (opens in a new tab)

  Oct 1, 2026

• ABBV Stock Rises 25% in 6 Months: Time to Buy, Hold or Sell? (opens in a new tab)

  Oct 1, 2026

• Was The Run In JNJ Stock Hiding In Plain Sight? (opens in a new tab)

  Sep 30, 2026

• AbbVie Stock: Buy, Sell, or Hold in October? (opens in a new tab)

  The Motley Fool · Sep 30, 2026

• 3 Healthcare Dividend Stocks Offering More Than Just Income (opens in a new tab)

  Sep 30, 2026

• Are You Overpaying For Pfizer Stock Versus Its Rivals? (opens in a new tab)

  Sep 30, 2026

• What Does AbbVie (ABBV) Need To Prove After Its Eczema Drug And AI Update? (opens in a new tab)

  Yahoo Finance · Sep 30, 2026

• What Is Merck Stock's Biggest Opportunity? (opens in a new tab)

  Trefis · Sep 30, 2026

• 1 Profitable Stock to Keep an Eye On and 2 Facing Challenges (opens in a new tab)

  StockStory · Sep 30, 2026

• BofA Boosts AbbVie and J&J Price Targets on Growth and Pipeline Strength (opens in a new tab)

  24/7 Wall St. · Sep 30, 2026

• AbbVie reports positive phase 2 data for Zumilokibart in atopic dermatitis (opens in a new tab)

  Seeking Alpha · Sep 30, 2026

• AbbVie Highlights Positive Results from the Phase 2 APEX Part B Study of Zumilokibart in Moderate to Severe Atopic Dermatitis, as a Late Breaker at EADV 2026 (opens in a new tab)

  Yahoo Finance · Sep 30, 2026

• AbbVie (ABBV) Falls More Steeply Than Broader Market: What Investors Need to Know (opens in a new tab)

  Zacks · Sep 29, 2026

• Defensive Dividends: 3 Companies Investors Can Rely On (opens in a new tab)

  Zacks · Sep 29, 2026

• Is Eli Lilly Stock a Good Fit For Your Portfolio Risk? (opens in a new tab)

  Trefis · Sep 29, 2026

• Final Trade: Abbvie, Advanced Micro, SpaceX, Eaton Corp. (opens in a new tab)

  CNBC · Sep 29, 2026

• Amazon, Walmart Surplus Auctioneer Climbs Toward A Breakout; Stock Up 45% (opens in a new tab)

  Investor's Business Daily · Sep 29, 2026